VALERIE ZAVALUNOV: Open Payments
NPI 1003686890 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 31 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $883 · 2025 $1,266
Food & beverage: $702Education: $564
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $394 |
| Aveo Pharmaceuticals, Inc. | 2 | $116 |
| Daiichi Sankyo Inc. | 2 | $107 |
| Janssen Biotech, Inc. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| Agios Pharmaceuticals, Inc. | 2 | $64 |
| Caris MPI, Inc. | 2 | $54 |
| Exelixis Inc. | 2 | $52 |
| SOBI, INC | 2 | $50 |
Products named: ENHERTU, FOTIVDA, Xtandi, ERLEADA, PYRUKYND, MI CANCER SEEK, LEQVIO, CABOMETYX.
Industry payments across MA — which companies pay providers there.
